home All News open_in_new Full Article

Nadofaragene firadenovec elicits high CR rate in phase 3 trial in Japan

Nadofaragene firadenovec elicits high CR rate in phase 3 trial in Japan  Urology Times


today 24 h. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 1238153787
Add Watch Country

arrow_drop_down